Rajat Bansal

Rajat Bansal practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Rajat Bansal's NPI, 1780002477, was assigned on March 31, 2014. Rajat Bansal graduated from Albany Medical College of Union University in 2014. Rajat Bansal holds Kansas license 04-43281.

Rajat Bansal's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Rajat Bansal's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Rajat Bansal is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Rajat Bansal to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajat Bansal practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rajat Bansal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Rajat Bansal is licensed in Kansas.

CMS data shows 979 Medicare services from Rajat Bansal across 8 procedure codes in 2024, for 166 Medicare patients. Medicare paid $69,870 for them.

CMS counts 166 Medicare patients who saw Rajat Bansal in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajat Bansal's median patient age at 69, with 39% women.

In 2024, Rajat Bansal wrote 744 Medicare Part D claims for 108 patients. 80% of them were for generic drugs. CMS names the drug for 478 of them, across 22 drugs with 11 or more claims each, at $545,113 in total drug cost. In 2023, CMS named 664 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Rajat Bansal for performance year 2024, reported through an alternative payment model (APM). Rajat Bansal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rajat Bansal as offering telehealth.

Dmand AI links 26 papers to Rajat Bansal, published from 2010 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Hematopoietic Stem Cell Transplantation, Graft vs Host Disease and Transplantation, Homologous. Rajat Bansal has published most often in Leuk Lymphoma. Rajat Bansal's most frequent co-authors are Nausheen Ahmed, MD, Muhammad Umair Mushtaq, MD and Sunil H. Abhyankar, MD.

CMS Open Payments shows 2 general payments to Rajat Bansal from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Genmab U.S., Inc. paid the most, $124.

Rajat Bansal graduated from Albany Medical College of Union University in 2014.